IL33 and endometriosis: Using our well-established syngeneic allograft murine model of endometriosis, we demonstrate that exogenous peritoneal IL-33 administration led to hallmarks of severe endometriosis: excess peritoneal inflammation, immune cell recruitment, lesion proliferation, lesion neurogenesis, and lesion collagen deposition.